BAA - Develop Inter-Lab Repeatability and Reproducibility (R&R) Study for V
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $1,500,000 to $3,000,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541380 Testing Laboratories and Services
- Points of contact
-
- CTP Acquisition Liaison ctpacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration (FDA) is seeking a contractor to develop an inter-laboratory repeatability and reproducibility (R&R) study for validating the reliability of a universal smoking machine adaptor design. This Broad Agency Announcement (BAA) represents a new requirement with no set-aside restrictions. The solicitation is expected to be released on January 1, 2026, with an estimated award date of August 1, 2026.
The estimated contract value ranges from $1,500,000 to $3,000,000, with the work falling under NAICS code 541380 (Testing Laboratories and Services). Interested contractors should direct inquiries to the FDA's acquisitions mailbox at ctpacquisitions@fda.hhs.gov. The project timeline extends approximately seven months from solicitation release to award, providing contractors with a defined schedule for proposal development and evaluation.
Forecast text
BAA - Develop Inter-Lab Repeatability and Reproducibility (R&R) Study for Validating Reliability of Universal Smoking Machine Adaptor Design
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast